Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000403529

Medchemexpress LLC Navitoclax-piperazine | 2143096-93-7 | 99.7% | 973.63 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY444325MG

Encompass_Preferred

Navitoclax-piperazine is an analog of Navitoclax and a BCL-XL inhibitor. It acts as a ligand for the target protein of PROTAC DT2216. Navitoclax-piperazine and E3 ubiquitin ligase VHL ligand can be used to synthesize PROTAC DT2216.

  • Is an analog of Navitoclax and a BCL-XL inhibitor.
  • Is the ligand for the target protein of PROTAC DT2216.
  • Can be used with E3 ubiquitin ligase VHL ligand to synthesize PROTAC DT2216.
  • For research use only.
  • Appearance: solid, white to off-white.

Catalog No. 50-004-03529


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.